ImmuCell Gross Margin 2010-2024 | ICCC
Current and historical gross margin for ImmuCell (ICCC) over the last 10 years. The current gross profit margin for ImmuCell as of December 31, 2024 is %.
| ImmuCell Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.03B | $0.01B | 30.77% |
| 2024-09-30 | $0.02B | $0.01B | 26.09% |
| 2024-06-30 | $0.02B | $0.01B | 22.73% |
| 2024-03-31 | $0.02B | $0.01B | 23.81% |
| 2023-12-31 | $0.02B | $0.00B | 17.65% |
| 2023-09-30 | $0.02B | $0.00B | 18.75% |
| 2023-06-30 | $0.02B | $0.00B | 25.00% |
| 2023-03-31 | $0.02B | $0.01B | 31.25% |
| 2022-12-31 | $0.02B | $0.01B | 42.11% |
| 2022-09-30 | $0.02B | $0.01B | 50.00% |
| 2022-06-30 | $0.02B | $0.01B | 50.00% |
| 2022-03-31 | $0.02B | $0.01B | 47.62% |
| 2021-12-31 | $0.02B | $0.01B | 47.37% |
| 2021-09-30 | $0.02B | $0.01B | 44.44% |
| 2021-06-30 | $0.02B | $0.01B | 47.06% |
| 2021-03-31 | $0.02B | $0.01B | 46.67% |
| 2020-12-31 | $0.02B | $0.01B | 43.75% |
| 2020-09-30 | $0.02B | $0.01B | 43.75% |
| 2020-06-30 | $0.02B | $0.01B | 40.00% |
| 2020-03-31 | $0.02B | $0.01B | 40.00% |
| 2019-12-31 | $0.01B | $0.01B | 42.86% |
| 2019-09-30 | $0.01B | $0.01B | 38.46% |
| 2019-06-30 | $0.01B | $0.01B | 41.67% |
| 2019-03-31 | $0.01B | $0.01B | 41.67% |
| 2018-12-31 | $0.01B | $0.00B | 36.36% |
| 2018-09-30 | $0.01B | $0.00B | 36.36% |
| 2018-06-30 | $0.01B | $0.00B | 36.36% |
| 2018-03-31 | $0.01B | $0.00B | 40.00% |
| 2017-12-31 | $0.01B | $0.01B | 45.45% |
| 2017-09-30 | $0.01B | $0.01B | 50.00% |
| 2017-06-30 | $0.01B | $0.01B | 50.00% |
| 2017-03-31 | $0.01B | $0.01B | 50.00% |
| 2016-12-31 | $0.01B | $0.01B | 55.56% |
| 2016-09-30 | $0.01B | $0.01B | 60.00% |
| 2016-06-30 | $0.01B | $0.01B | 70.00% |
| 2016-03-31 | $0.01B | $0.01B | 70.00% |
| 2015-12-31 | $0.01B | $0.01B | 70.00% |
| 2015-09-30 | $0.01B | $0.01B | 66.67% |
| 2015-06-30 | $0.01B | $0.01B | 55.56% |
| 2015-03-31 | $0.01B | $0.01B | 55.56% |
| 2014-12-31 | $0.01B | $0.00B | 50.00% |
| 2014-09-30 | $0.01B | $0.00B | 50.00% |
| 2014-06-30 | $0.01B | $0.00B | 57.14% |
| 2014-03-31 | $0.01B | $0.00B | 66.67% |
| 2013-12-31 | $0.01B | $0.00B | 66.67% |
| 2013-09-30 | $0.01B | $0.00B | 80.00% |
| 2013-06-30 | $0.01B | $0.00B | 80.00% |
| 2013-03-31 | $0.01B | $0.00B | 80.00% |
| 2012-12-31 | $0.01B | $0.00B | 80.00% |
| 2012-09-30 | $0.01B | $0.00B | 80.00% |
| 2012-06-30 | $0.01B | $0.00B | 80.00% |
| 2012-03-31 | $0.01B | $0.00B | 80.00% |
| 2011-12-31 | $0.01B | $0.00B | 80.00% |
| 2011-09-30 | $0.01B | $0.00B | 80.00% |
| 2011-06-30 | $0.01B | $0.00B | 60.00% |
| 2011-03-31 | $0.01B | $0.00B | 60.00% |
| 2010-12-31 | $0.00B | $0.00B | 75.00% |
| 2010-09-30 | $0.00B | $0.00B | 75.00% |
| 2010-06-30 | $0.00B | $0.00B | 100.00% |
| 2010-03-31 | $0.00B | $0.00B | 75.00% |
| 2009-12-31 | $0.00B | $0.00B | 75.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.046B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.503B | 27.84 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $144.095B | 30.13 |
| EssilorLuxottica (ESLOY) | France | $132.622B | 0.00 |
| Medtronic (MDT) | Ireland | $105.579B | 15.42 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.866B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.124B | 27.36 |
| ResMed (RMD) | United States | $35.477B | 26.65 |
| GE HealthCare Technologies (GEHC) | United States | $30.720B | 14.59 |
| Agilent Technologies (A) | United States | $30.004B | 19.82 |
| Terumo (TRUMY) | Japan | $29.197B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.643B | 16.28 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.255B | 11.72 |
| Insulet (PODD) | United States | $18.215B | 77.74 |
| Baxter (BAX) | United States | $15.352B | 11.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.179B | 17.65 |
| Bio-Rad Laboratories (BIO) | United States | $6.487B | 21.93 |
| Prestige Consumer Healthcare (PBH) | United States | $4.014B | 19.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.368B | 9.64 |
| ICU Medical (ICUI) | United States | $3.306B | 28.16 |
| Haemonetics (HAE) | United States | $3.194B | 15.03 |
| Envista Holdings (NVST) | United States | $2.778B | 23.08 |
| GN Store Nord (GNNDY) | Denmark | $2.069B | 17.14 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.46 |
| QuidelOrtho (QDEL) | United States | $1.750B | 14.65 |
| AtriCure (ATRC) | United States | $1.478B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.281B | 20.17 |
| AdaptHealth (AHCO) | United States | $1.194B | 12.12 |
| Neogen (NEOG) | United States | $1.192B | 15.25 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.043B | 0.00 |
| InMode (INMD) | Israel | $0.995B | 9.11 |
| Phibro Animal Health (PAHC) | United States | $0.771B | 11.83 |
| Evolus (EOLS) | United States | $0.749B | 0.00 |
| Owens & Minor (OMI) | United States | $0.596B | 5.07 |
| Curaleaf Holdings (CURLF) | Canada | $0.579B | 0.00 |
| CeriBell (CBLL) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.420B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 14.75 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.302B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.292B | 26.43 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 46.10 |
| ZimVie (ZIMV) | United States | $0.245B | 14.65 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.184B | 4.21 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.16 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 50.65 |
| Organigram Global (OGI) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 17.99 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.58 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |